← SynDRA
2-METHOXYESTRADIOL
SynDRA canonical compound SYN0002393 — structure-anchored drug synonym record
Clinical phase
Phase 2
Primary target(s)
CASP3 | COMT | CYP19A1 | CYP1A1 | CYP1B1 | HIF1A | TNFRSF10B | TUBB
Mechanism of action
hypoxia inducible factor inhibitor
All known targets
HIF1A
CASP3
COMT
CYP19A1
CYP1A1
CYP1B1
GPER1
TNFRSF10B
TUBB
Mechanisms of action (all sources)
GPER1 AGONIST
hypoxia inducible factor inhibitor
HIF1A MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
APOBEC3G
ATAD5
TDP1
TARDBP
SLC22A1
SHBG
RGS4
PMP22
NFE2L2
MTOR
MPHOSPH8
MAPT
LMNA
IDH1
HDAC6
GMNN
GLP1R
GBA1
GAA
ESR2
ESR1
EHMT2
CBX1
BLM
ATXN2
UGT2B7
Cross-references
PubChem CID:
66414
ChEMBL:
CHEMBL299613
DrugBank:
DB02342
ChEBI:
28955
KEGG:
C05302
PDB:
ESM
Wikipedia:
2-Methoxyestradiol
TTD: D06NYA
LINCS BRD: BRD-K44408410
Synonyms
2-methoxyoestradiol
NSC-659853
ESM
Panzem
PulmoLAR
Panzem NCD
M 6383
(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol
(17beta)-2-methoxyestra-1(10),2,4-triene-3,17-diol
(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER
1,3,5(10)-Estratriene-2,3,17-triol 2-methyl ether
2,3,17beta-Trihydroxy-1,3,5(10)-estratriene 2-methyl ether
2-Hydroxyestradiol 2-methyl ether
2-Hydroxyestradol 2-methyl ether
2-ME2, 2-Methoxyestradiol
2-Methoxyestra-1,3,5(10)-triene-3,17beta-diol
2-Methoxyestradiol-17beta
3,17beta-Dihydroxy-2-methoxy-1,3,5(10)-estratriene
BRD-K44408410
2-ME2
2ME2
2-Methoxy 17beta-Estradiol
2 Methoxyoestradiol
NSC 659853
6I2QW73SR5
Estra-1,3,5(10)-triene-3,17-diol, 2-methoxy-, (17beta)-
2-methoxy-estra-1,3,5(10)-triene-3,17beta-diol
CHEBI:28955
2 Methoxyestradiol 17 beta
RefChem:388747
DTXCID1020938
(17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol
2-Methoxyestradiol (2-MeOE2)
Estradiol, 2-methoxy-
2-Methoxy-beta-estradiol
MFCD00010489
2-methoxy Estradiol
Look up 2-METHOXYESTRADIOL in the interactive SynDRA portal →